According to the studies included in the meta-analysis, treating vitiligo mouse models with antigen-specific CAR Tregs, PD-L1 fusion peptides, and CCL22 DNA reverses depigmentation by increasing the number of Tregs and FOXP3 expression in the skin [47, 50, 51]. This evidence concerns the gene CD274 and vitiligo.